Who owns the AGMI trademark?

The AGMI trademark is owned by Avant-Garde Medical Innovation LLC.

What class is the AGMI trademark registered in?

The AGMI trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for AGMI?

The USPTO serial number for AGMI is 97643978.

What is the registration number for AGMI?

AGMI is registered under USPTO registration number 7804003.

Sealvo

Home Search: AGMIAGMI #97643978

Back

Updated Oct 25, 2026·16 searches this week

View on USPTO TSDR Find similar marks

AGM

USPTO Trademark Record

REGISTERED

AGMI

SN 97643978·Reg 7804003·Filed Oct 23, 2022

Owner Avant-Garde Medical Innovation LLC

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

AGMI (Serial No. 97643978), Registration No. 7804003, is a registered US trademark filed on Oct 23, 2022 by Avant-Garde Medical Innovation LLC. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: May 20, 2031

Mark Intelligence

AGMI (Reg. #7804003) is a registered US trademark that has been protecting its owner, Avant-Garde Medical Innovation LLC, since 2022. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Oct 23, 2022

SERIAL

97643978

REG#

7804003

REGISTERED

May 20, 2025

Filing Information

StatusREGISTERED

Filing DateOct 23, 2022

Serial Number97643978

Registration No.7804003

Registration DateMay 20, 2025

Status DateMay 20, 2025

Published for OppositionMar 21, 2023

Filing Basis & Declarations

Use Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Jan 09, 2025

First use in commerce: Jan 09, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

58 events

REGISTERED-PRINCIPAL REGISTER

May 20, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

May 20, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Apr 26, 2025

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Apr 26, 2025

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ASSIGNED TO LIE

Mar 12, 2025

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 11, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 11, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 28, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

SU - NON-FINAL ACTION - WRITTEN

Feb 09, 2025

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Feb 09, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 09, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Jan 17, 2025

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Jan 09, 2025

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Jan 09, 2025

USE AMENDMENT FILED

SOU EXTENSION 3 GRANTED

Dec 18, 2024

SOU EXTENSION 3 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 18, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

ABANDONMENT - NO USE STATEMENT FILED

Dec 16, 2024

ABANDONMENT - NO USE STATEMENT FILED

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Dec 16, 2024

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

TEAS PETITION TO REVIVE RECEIVED

Dec 16, 2024

TEAS PETITION TO REVIVE RECEIVED

PETITION TO REVIVE-GRANTED

Dec 16, 2024

PETITION TO REVIVE-GRANTED

NOTICE OF REVIVAL - E-MAILED

Dec 16, 2024

NOTICE OF REVIVAL - E-MAILED

SOU EXTENSION RECEIVED WITH TEAS PETITION

Dec 16, 2024

SOU EXTENSION RECEIVED WITH TEAS PETITION

SOU EXTENSION 3 FILED

Nov 16, 2024

SOU EXTENSION 3 FILED

SOU EXTENSION 2 GRANTED

Aug 14, 2024

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 14, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 12, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS PETITION TO REVIVE RECEIVED

Jun 18, 2024

TEAS PETITION TO REVIVE RECEIVED

PETITION TO REVIVE-GRANTED

Jun 18, 2024

PETITION TO REVIVE-GRANTED

NOTICE OF REVIVAL - E-MAILED

Jun 18, 2024

NOTICE OF REVIVAL - E-MAILED

SOU EXTENSION RECEIVED WITH TEAS PETITION

Jun 18, 2024

SOU EXTENSION RECEIVED WITH TEAS PETITION

ABANDONMENT - NO USE STATEMENT FILED

Jun 17, 2024

ABANDONMENT - NO USE STATEMENT FILED

SOU EXTENSION 2 FILED

May 16, 2024

SOU EXTENSION 2 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 07, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Nov 05, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Nov 05, 2023

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Nov 05, 2023

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 16, 2023

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Mar 21, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 21, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 01, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Feb 13, 2023

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Feb 13, 2023

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Feb 13, 2023

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Feb 13, 2023

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 13, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

PREVIOUS ALLOWANCE COUNT WITHDRAWN

Feb 13, 2023

PREVIOUS ALLOWANCE COUNT WITHDRAWN

EXAMINERS AMENDMENT -WRITTEN

Feb 13, 2023

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Feb 13, 2023

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Feb 13, 2023

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Feb 13, 2023

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 13, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

PREVIOUS ALLOWANCE COUNT WITHDRAWN

Jan 12, 2023

PREVIOUS ALLOWANCE COUNT WITHDRAWN

WITHDRAWN FROM PUB - OG REVIEW QUERY

Nov 29, 2022

WITHDRAWN FROM PUB - OG REVIEW QUERY

ASSIGNED TO EXAMINER

Nov 15, 2022

ASSIGNED TO EXAMINER

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 15, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Nov 08, 2022

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 07, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Oct 26, 2022

NEW APPLICATION ENTERED

Other Marks by Avant-Garde Medical Innovation LLC

Additional USPTO filings from the same owner.

MID

MIDAS

97733740

Avant-Garde Medical Innovation LLC

REGISTERED

PLE

PLEUROXEAL

97250022

Avant-Garde Medical Innovation LLC

ABANDONED

PLE

PLEUROXEAL

97643974

Avant-Garde Medical Innovation LLC

ABANDONED

AGMI

Run a conflict check

Other Marks by Avant-Garde Medical Innovation LLC

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company